The OptumRx class action settlement resolved allegations that the pharmacy benefit manager made prerecorded “clinical adherence” robocalls to the cell phones of people who were not its customers, in violation of the Telephone Consumer Protection Act. OptumRx agreed to pay $1.86 million into a non-reversionary fund without admitting wrongdoing. A federal judge in the Southern District of Indiana granted final approval on March 31, 2026, and checks were issued to approved claimants on May 29, 2026.1GovInfo. Patterson v. OptumRx Court Documents2OptumRx TCPA Class Action Settlement. Patterson vs. OptumRx Settlement Home
Who Was Covered
The settlement class included people anywhere in the United States who received a clinical adherence call from OptumRx between April 20, 2020, and October 22, 2025, on a cell phone or VoIP line that was not associated with an OptumRx customer or account holder, where the call used a prerecorded or artificial voice.3Justia. Patterson v. OptumRx, Preliminary Approval Order4OptumRx TCPA Class Action Settlement. Frequently Asked Questions5BenefitsPRO. OptumRx to Pay $1.9M to Settle Automated Health Coaching Call Class Action Suit
An estimated 155,244 unique phone numbers fell within the class definition. The claim, opt-out, and objection deadline was February 4, 2026, and only one person, Elizabeth Candelario, asked to be excluded. No class member objected.6ClassAction.org. $1.86M OptumRx Settlement Ends Litigation Over Alleged Prerecorded Voice Messages7GovInfo. Patterson v. OptumRx Final Approval Order
How Much Class Members Received
Approved claimants were estimated to receive between $72 and $135 each, depending on the total number of valid claims filed. That range sits above the typical TCPA class action payout, which often falls between $6 and $75 per person.6ClassAction.org. $1.86M OptumRx Settlement Ends Litigation Over Alleged Prerecorded Voice Messages8CompliancePoint. Plaintiff Incentive Awards Ruled Unlawful in TCPA Class Action Lawsuit
Payments were sent by check on May 29, 2026. Checks must be cashed by September 26, 2026, or they become void. Uncashed funds are directed to the National Legal Aid and Defender Association as a cy pres award.4OptumRx TCPA Class Action Settlement. Frequently Asked Questions9ClassAction.org. OptumRx Settlement Agreement
Where the $1.86 Million Went
The fund was non-reversionary, so nothing went back to OptumRx. The court approved these deductions before pro rata distribution to claimants:
- Roughly $207,750 to Kroll Settlement Administration LLC for notice and claims processing.10ClassAction.org. OptumRx Settlement Notice
- $580,796.42 in attorneys’ fees to class counsel.7GovInfo. Patterson v. OptumRx Final Approval Order
- $28,925.60 in litigation costs reimbursed to class counsel.7GovInfo. Patterson v. OptumRx Final Approval Order
- A $10,000 service award to named plaintiff Brad Patterson.7GovInfo. Patterson v. OptumRx Final Approval Order
What the Case Alleged
Brad Patterson filed suit on April 19, 2024, in the U.S. District Court for the Southern District of Indiana, alleging that OptumRx used artificial or prerecorded voice messages to place clinical adherence calls to cell phones and VoIP lines belonging to people who had no relationship with the company and had never consented to be contacted.6ClassAction.org. $1.86M OptumRx Settlement Ends Litigation Over Alleged Prerecorded Voice Messages The TCPA restricts automated calling systems and prerecorded messages, and it authorizes statutory damages of $500 to $1,500 per violating call.11Holland & Knight. TCPA Class Action Litigation
OptumRx denied any TCPA violation and said it settled to avoid the cost and uncertainty of continued litigation.9ClassAction.org. OptumRx Settlement Agreement The case was dismissed with prejudice at final approval.7GovInfo. Patterson v. OptumRx Final Approval Order
What This Settlement Does Not Cover
This case dealt only with alleged prerecorded robocalls to non-customers. It is separate from other legal matters involving OptumRx and parent UnitedHealth Group, including an FTC administrative case over insulin pricing practices (in settlement discussions as of June 2026) and an ongoing Justice Department criminal investigation into UnitedHealth’s pharmacy management and physician reimbursement practices.12Fierce Healthcare. Optum Rx, FTC Posed Settlement in Insulin Pricing Case13UnitedHealth Group. UHG Responds to DOJ Investigation Nothing paid under the TCPA settlement relates to those matters.